復(fù)溶 |
LyGDI is a promising biomarker for ovarian cancer. Zhen H, et al. Int J Gynecol Cancer, 2010 Apr. PMID 20375790.Pathways of metastasis suppression in bladder cancer. Said N, et al. Cancer Metastasis Rev, 2009 Dec. PMID 20013033.Genetic susceptibility to distinct bladder cancer subphenotypes. Guey LT, et al. Eur Urol, 2010 Feb. PMID 19692168.PTEN identified as important risk factor of chronic obstructive pulmonary disease. Hosgood HD 3rd, et al. Respir Med, 2009 Dec. PMID 19625176.Consensus transcriptome signature of perineural invasion in pancreatic carcinoma. Abiatari I, et al. Mol Cancer Ther, 2009 Jun. PMID 19509238.
|
儲(chǔ)存溶液 |
Rho GDP-dissociation inhibitor 2, Rho GDI 2, Ly-GDI, Rho-GDI beta, ARHGDIB, GDIA2, GDID4, RAP1GN1
|